France Cardiovascular Ultrasound Market No. of Pages- 173
Opportunity Analysis and Industry Forecast, 2016-2023
Global Opportunity Analysis and Industry Forecast, 2021-2030 Download Report Sample
France Cardiovascular Ultrasound Market France Cardiovascular Ultrasound Market by Clinical Application, Technology, Device Display, Age Group, and End User: Opportunity Analysis and Industry Forecast, 2021–2030 The France cardiovascular ultrasound market was valued at $162.97 million in 2020, and is projected to reach $252.90 million by 2030, registering a CAGR of 4.7% from 2021 to 2030. Cardiac ultrasound, also known as echocardiography, refers to the ultrasound imaging of the heart. It examines the structure and function of the heart and related vessels. Image analysis is driven by technology, as diagnosing heart disease requires a fairly detailed view of the heart and blood movement. Therefore, ultrasound systems can be highly specialized for this area. It is a graphic outline of the heart's movement.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/15372
France Cardiovascular Ultrasound Market
The key factors that boost the growth of the France cardiovascular ultrasound market include increased advantages of echocardiography over invasive cardiac diagnostic procedures and surge in incidence of cardiovascular diseases (CVDs). In addition, this technology is widely accepted among patients as it is non-invasive, hence shortens the stay at hospitals, which fuels the market growth. However, factors such as economic influence of approving new technologies and insufficient reimbursement scenario impede the growth of the market. Conversely, technological advancements leading in cardiac specific technologies such as tissue enhancements, lateral gain control, advanced dynamic flow, tissue Doppler, and stress echo provide lucrative opportunities for the growth of the market
Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/15372
France Cardiovascular Ultrasound Market By technology, it is classified into 2D, 3D & 4D, and Doppler imaging. The 2D segment accounted for maximum France cardiovascular ultrasound market revenue in 2020, and is anticipated to maintain its dominance during the forecast period. This is attributed to surge in the geriatric population and change in lifestyle of the people, which are anticipated to drive the market growth. However, the 3D & 4D segment exhibits fastest growth from 2021 to 2030 owing to increase in the number of heart patients and rise in the awareness of diagnosis via ultrasound devices. Moreover, availability of large number of advanced hospitals, presence of skilled medical professionals, large number of ambulatory centers, and wide usage of medical nonwoven products are anticipated to drive the growth of the segment. By device display, it is classified into color display, and black &white display. The color display segment accounted for maximum market revenue in 2020, and is anticipated to maintain its dominance during the forecast period. This is attributed to the increasing advantages of echocardiography over invasive cardiac diagnostic procedures, and surge in incidence of cardiovascular diseases (CVDs), which are projected to foster the France cardiovascular ultrasound market growth. By age group, it is classified into adult and pediatric. The adult segment accounted for maximum France cardiovascular ultrasound market revenue in 2020, and is anticipated to maintain its dominance during the forecast period. This is attributed to the increasing population of adult people and rise in incidence of cardiovascular diseases (CVDs) in that age group that are anticipated to drive the market growth.
France Cardiovascular Ultrasound Market
The Major Key Players Are:
Canon Inc. (Canon Medical System Corporation) Esaote S.p.A Fujifilm Holding Corporation General Electric Company Hitachi Ltd Koninklijke Philips N.V. Mindray Medical International Limited Samsung Group Siemens AG SuperSonic Imagine
France Cardiovascular Ultrasound Market
Key Findings of the Study: By type, the positive expiratory pressure (PEP) segment accounted for the highest market share of 27% in 2018 and is anticipated to grow at the fastest rate during the forecast period. By region, North America was the major shareholder and accounted for the highest share of 44% in 2018. By application, neuromuscular segment is expected to grow at a CAGR of 5.4% during the forecast period. By end user, the hospitals segment dominated the market in 2018 and is anticipated to maintain its dominance during the forecast period.
France Cardiovascular Ultrasound Market
Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free (USA/Canada): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-855-550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com